Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis

Simons, 2002, H1-antihistamines in children, 437 The International Study of Asthma and Allergies in Childhood ISAAC Steering Committee, 1998, Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC, Lancet, 351, 1225, 10.1016/S0140-6736(97)07302-9 Meltzer, 1995, An overview of current pharmacotherapy in perennial rhinitis, J Allergy Clin Immunol, 95, 1097, 10.1016/S0091-6749(95)70213-X Malone, 1997, A cost of illness study of allergic rhinitis in the United States, J Allergy Clin Immunol, 99, 22 Vuurman, 1993, Seasonal allergic rhinitis and antihistamine effects on children's learning, Ann Allergy, 71, 121 Leynaert, 2000, Epidemiologic evidence for asthma and rhinitis comorbidity, J Allergy Clin Immunol, 106, S201, 10.1067/mai.2000.110151 Settipane, 1999, Complications of allergic rhinitis, Allergy Asthma Proc, 20, 209, 10.2500/108854199778339053 Meltzer, 2001, Quality of life in adults and children with allergic rhinitis, J Allergy Clin Immunol, 108, S45, 10.1067/mai.2001.115566 Craig, 1998, Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids, J Allergy Clin Immunol, 101, 633, 10.1016/S0091-6749(98)70171-X Skoner, 1997, Control of allergic rhinitis with antihistamines may prevent the onset or recurrence of otitis media, Pediatr Asthma Allergy Immunol, 11, 193, 10.1089/pai.1997.11.193 Shapiro, 1988, The role of nasal airway obstruction in sinus disease and facial development, J Allergy Clin Immunol, 82, 935, 10.1016/0091-6749(88)90036-X Simons, 1996, Learning impariment and allergic rhinitis, Allergy Asthma Proc, 17, 185, 10.2500/108854196778996895 Pearlman, 1997, Once-daily cetirizine effective in the treatment of seasonal allergic rhinitis in children aged 6 to 11 years: a randomized, double-blind, placebo-controlled study, Clin Pediatr (Phila), 209, 10.1177/000992289703600405 Ciprandi, 1997, Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity, Clin Exp Allergy, 27, 1160, 10.1111/j.1365-2222.1997.tb01153.x Baelde, 1992, Cetirizine in children with chronic allergic rhinitis: a multicentre double-blind study of two doses of cetirizine and placebo, Drug Invest, 4, 466, 10.1007/BF03259210 Masi, 1993, A placebo-controlled trial of cetirizine in seasonal allergic rhino-conjunctivitis in children aged 6 to 12 years, Pediatr Allergy Immunol, 4, 47 Tinkelman, 1996, Treatment of seasonal allergic rhinitis in children with cetirizine or chlorpheniramine: a multicenter study, Pediatr Asthma Allergy Immunol, 10, 9, 10.1089/pai.1996.10.9 Serra, 1998, Loratadine-pseudoephedrine in children with allergic rhinitis, a controlled double-blind trial, Br J Clin Pharmacol, 45, 147, 10.1046/j.1365-2125.1998.00657.x Wober, 1997, Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age, Arzneimittelforschung, 47, 841 Howarth, 1999, Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120mg and 180 mg once-daily) and cetirizine in seasonal allergic rhinitis, J Allergy Clin Immunology, 104, 927, 10.1016/S0091-6749(99)70070-9 Finn, 1999, A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria, J Allergy Clin Immunol, 104, 1071, 10.1016/S0091-6749(99)70091-6 Casale, 1999, Safety and efficacy of once-daily fexofen-adine HCl in the treatment of autumn seasonal allergic rhinitis, Allergy Asthma Proc, 20, 193, 10.2500/108854199778553046 Mosges, 2000, fexofenadine and loratadine exhibit rapid onset of relief, but only fexofenadine maintains efficacy over a 2-week study period, Allergy, 55, 281 Simons, 1996, The clinical pharmacology of fexofenadine in children, J Allergy Clin Immunol, 98, 1062, 10.1016/S0091-6749(96)80192-8 Graft, 2001, Safety of fexofenadine in children treated for seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 87, 22, 10.1016/S1081-1206(10)62317-4 Bousquet, 2001, World Health Organization. Allergic rhinitis and its impact on asthma, J Allergy Clin Immunol, 108, S147, 10.1067/mai.2001.118891 Corren, 1997, Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma, J Allergy Clin Immunol, 100, 781, 10.1016/S0091-6749(97)70274-4 Aubier, 2001, Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma, Allergy, 56, 35, 10.1034/j.1398-9995.2001.00629.x Nelson, 2001, The importance of allergens in the development of asthma and the persistence of symptoms, Dis Mon, 47, 5, 10.1067/mai.2000.da0470005 Warner, 2001, A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' post-treatment follow-up, J Allergy Clin Immunol, 108, 929, 10.1067/mai.2001.120015 Meltzer, 1995, Histamine levels and nasal cytology in children with chronic otitis media and rhinitis, Ann Allergy Asthma Immunol, 74, 406 Watson, 1995, Nasal patency in children with allergic rhinitis: correlation of objective and subjective assessments, Ann Allergy Asthma Immunol, 74, 237 Van Cauwenberge, 2000, Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis, Clin Exp Allergy, 30, 891, 10.1046/j.1365-2222.2000.00914.x Abdelaziz, 1998, Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis, J Allergy Clin Immunol, 101, 410, 10.1016/S0091-6749(98)70256-8 Marone, 2001, Histamine-induced activation of human lung macrophages, Int Arch Allergy Immunol, 124, 249, 10.1159/000053725 Paolieri, 1998, Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines, Ann Allergy Asthma Immunol, 81, 601, 10.1016/S1081-1206(10)62712-3 Simons, 2001, Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast, Ann Allergy Asthma Immunol, 86, 44, 10.1016/S1081-1206(10)62354-X Triggiani, 2001, Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors, J Immunol, 266, 4083, 10.4049/jimmunol.166.6.4083 Mason, 1999, The systematic safety of fexofenadine HCI, Clin Exp Allergy, 29, 163, 10.1046/j.1365-2222.1999.0290s3163.x Nathan, 1999, The long-term safety and tolerability of fexofenadine in healthy subjects, Clin Drug Invest, 18, 317, 10.2165/00044011-199918040-00008 Russell, 1998, Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers, Clin Pharmacol Ther, 64, 612, 10.1016/S0009-9236(98)90052-2